Literature DB >> 1557429

Erythropoietin: structure, control of production, and function.

W Jelkmann1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1557429     DOI： 10.1152/physrev.1992.72.2.449

Source DB:  PubMed          Journal:  Physiol Rev        ISSN： 0031-9333            Impact factor:   37.312


× No keyword cloud information.
  219 in total

1.  Prediction of mucin-type O-glycosylation sites by a two-staged strategy.

Authors:  YuDong Cai; JianFeng He; Lin Lu
Journal:  Mol Divers       Date:  2010-07-22       Impact factor: 2.943

2.  Erythropoietin and ventricular remodelling: a VEGF-dependent neovascularity.

Authors:  Tariq Hamid; Sumanth D Prabhu
Journal:  Cardiovasc Res       Date:  2010-05-05       Impact factor: 10.787

3.  Recombinant human erythropoietin antagonizes trastuzumab treatment of breast cancer cells via Jak2-mediated Src activation and PTEN inactivation.

Authors:  Ke Liang; Francisco J Esteva; Constance Albarracin; Katherine Stemke-Hale; Yang Lu; Giampaolo Bianchini; Ching-Yi Yang; Yong Li; Xinqun Li; Chun-Te Chen; Gordon B Mills; Gabriel N Hortobagyi; John Mendelsohn; Mien-Chie Hung; Zhen Fan
Journal:  Cancer Cell       Date:  2010-11-16       Impact factor: 31.743

4.  Erythropoietin down-regulates proximal renal tubular reabsorption and causes a fall in glomerular filtration rate in humans.

Authors:  Niels Vidiendal Olsen; Niels-Jacob Aachmann-Andersen; Peter Oturai; Thor Munch-Andersen; Andreas Bornø; Carl Hulston; Niels-Henrik Holstein-Rathlou; Paul Robach; Carsten Lundby
Journal:  J Physiol       Date:  2010-08-19       Impact factor: 5.182

5.  Models of Human AKI: Resemblance, Reproducibility, and Return on Investment.

Authors:  Karl A Nath
Journal:  J Am Soc Nephrol       Date:  2015-11-04       Impact factor: 10.121

6.  Hypoxic pulmonary vasoconstriction, carotid body function and erythropoietin production in adult rats perinatally exposed to hyperoxia.

Authors:  Jesus Prieto-Lloret; Maria Ramirez; Elena Olea; Javier Moral-Sanz; Angel Cogolludo; Javier Castañeda; Sara Yubero; Teresa Agapito; Angela Gomez-Niño; Asuncion Rocher; Ricardo Rigual; Ana Obeso; Francisco Perez-Vizcaino; Constancio González
Journal:  J Physiol       Date:  2015-05-15       Impact factor: 5.182

7.  Recombinant Human Erythropoietin: Novel Strategies for Neuroprotective/Neuro-regenerative Treatment of Multiple Sclerosis.

Authors:  Claudia Bartels; Kira Späte; Henning Krampe; Hannelore Ehrenreich
Journal:  Ther Adv Neurol Disord       Date:  2008-11       Impact factor: 6.570

8.  Ca2+-activated K+ channels in human melanoma cells are up-regulated by hypoxia involving hypoxia-inducible factor-1alpha and the von Hippel-Lindau protein.

Authors:  Nobuyoshi Tajima; Kristina Schönherr; Susanna Niedling; Martin Kaatz; Hiroshi Kanno; Roland Schönherr; Stefan H Heinemann
Journal:  J Physiol       Date:  2006-01-05       Impact factor: 5.182

9.  Gene therapy for long-term expression of erythropoietin in rats.

Authors:  W R Osborne; N Ramesh; S Lau; M M Clowes; D C Dale; A W Clowes
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

Review 10.  Erythropoietin.

Authors:  H Franklin Bunn
Journal:  Cold Spring Harb Perspect Med       Date:  2013-03-01       Impact factor: 6.915
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.